An Add-on Study of MLR-1023 in Adults With Uncontrolled Type 2 Diabetes on Metformin Therapy

NCT03279263 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

400

Enrollment

OTHER

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: MLR-1023
OTHER: Placebo

Sponsor

Melior Pharmaceuticals

Collaborators

[object Object]